Rockwell Medical Investor Relations Material
Latest events
Q4 2023
Rockwell Medical
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Rockwell Medical Inc
Access all reports
Rockwell Medical, Inc., biopharmaceutical company, targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. It offers dialysis concentrates/dialysates and manufactured drugs, including Triferic (ferric pyrophosphate citrate), an iron replacement product for hemodialysis; Calcitriol injection, a vitamin D analog; Soluble Ferric Pyrophosphate (SFP) injection to treat iron deficient anemia; Rockwell's GranuFlo powder for oral solution; and Hematogenix SV Dialysis tests.
Latest articles
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
Ticker symbol
Country
🇺🇸 United States